150 related articles for article (PubMed ID: 34418751)
21. Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro.
Kadife E; Hannan N; Harper A; Binder N; Beard S; Brownfoot FC
PLoS One; 2022; 17(11):e0271560. PubMed ID: 36417467
[TBL] [Abstract][Full Text] [Related]
22. Circulatory and Placental Expression of Soluble Fms-like Tyrosine Kinase- 1 and Placental Growth Factor in HIV-infected Preeclampsia.
Mlambo ZP; Khaliq OP; Moodley J; Naicker T
Curr Hypertens Rev; 2023; 19(1):27-33. PubMed ID: 36453504
[TBL] [Abstract][Full Text] [Related]
23. Effects of Pravastatin on Human Placenta, Endothelium, and Women With Severe Preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Binder NK; Walker SP; Cannon P; Hastie R; Onda K; Kaitu'u-Lino TJ
Hypertension; 2015 Sep; 66(3):687-97; discussion 445. PubMed ID: 26222708
[TBL] [Abstract][Full Text] [Related]
24. Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies.
Hoeller A; Ehrlich L; Golic M; Herse F; Perschel FH; Siwetz M; Henrich W; Dechend R; Huppertz B; Verlohren S
Hypertens Pregnancy; 2017 May; 36(2):151-160. PubMed ID: 28609172
[TBL] [Abstract][Full Text] [Related]
25. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
[TBL] [Abstract][Full Text] [Related]
26. Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.
Palmer KR; Kaitu'u-Lino TJ; Hastie R; Hannan NJ; Ye L; Binder N; Cannon P; Tuohey L; Johns TG; Shub A; Tong S
Hypertension; 2015 Dec; 66(6):1251-9. PubMed ID: 26416849
[TBL] [Abstract][Full Text] [Related]
27. Total Versus Free Placental Growth Factor Levels in the Pathogenesis of Preeclampsia.
Lecarpentier E; Zsengellér ZK; Salahuddin S; Covarrubias AE; Lo A; Haddad B; Thadhani RI; Karumanchi SA
Hypertension; 2020 Sep; 76(3):875-883. PubMed ID: 32654553
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of hyperglycemia-induced apoptotic signaling and anti-angiogenic milieu in cultured cytotrophoblast cells.
Cawyer C; Afroze SH; Drever N; Allen S; Jones R; Zawieja DC; Kuehl T; Uddin MN
Hypertens Pregnancy; 2016 May; 35(2):159-69. PubMed ID: 26930265
[TBL] [Abstract][Full Text] [Related]
29. Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.
Fujii T; Nagamatsu T; Morita K; Schust DJ; Iriyama T; Komatsu A; Osuga Y; Fujii T
Sci Rep; 2017 Sep; 7(1):12455. PubMed ID: 28963486
[TBL] [Abstract][Full Text] [Related]
30. Effects of pravastatin on angiogenic and placental hypoxic imbalance in a mouse model of preeclampsia.
Saad AF; Kechichian T; Yin H; Sbrana E; Longo M; Wen M; Tamayo E; Hankins GD; Saade GR; Costantine MM
Reprod Sci; 2014 Jan; 21(1):138-45. PubMed ID: 23749761
[TBL] [Abstract][Full Text] [Related]
31. Placental Growth Factor Administration Abolishes Placental Ischemia-Induced Hypertension.
Spradley FT; Tan AY; Joo WS; Daniels G; Kussie P; Karumanchi SA; Granger JP
Hypertension; 2016 Apr; 67(4):740-7. PubMed ID: 26831193
[TBL] [Abstract][Full Text] [Related]
32. Loss of placental growth factor ameliorates maternal hypertension and preeclampsia in mice.
Parchem JG; Kanasaki K; Kanasaki M; Sugimoto H; Xie L; Hamano Y; Lee SB; Gattone VH; Parry S; Strauss JF; Garovic VD; McElrath TF; Lu KH; Sibai BM; LeBleu VS; Carmeliet P; Kalluri R
J Clin Invest; 2018 Nov; 128(11):5008-5017. PubMed ID: 30179860
[TBL] [Abstract][Full Text] [Related]
33. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor.
Shibata E; Rajakumar A; Powers RW; Larkin RW; Gilmour C; Bodnar LM; Crombleholme WR; Ness RB; Roberts JM; Hubel CA
J Clin Endocrinol Metab; 2005 Aug; 90(8):4895-903. PubMed ID: 15886253
[TBL] [Abstract][Full Text] [Related]
34. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
[TBL] [Abstract][Full Text] [Related]
35. Ghrelin alleviates placental dysfunction by down-regulating NF-κB phosphorylation in LPS-induced rat model of preeclampsia.
Shen J; Hu N; Wang Z; Yang L; Chen R; Zhang L; Wang X
Eur J Pharmacol; 2024 Jun; 972():176569. PubMed ID: 38593930
[TBL] [Abstract][Full Text] [Related]
36. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
Stepan H; Hund M; Andraczek T
Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
[TBL] [Abstract][Full Text] [Related]
37. Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy.
Gurnadi JI; Mose J; Handono B; Satari MH; Anwar AD; Fauziah PN; Yogi Pramatirta A; Rihibiha DD
BMC Res Notes; 2015 Oct; 8():534. PubMed ID: 26434493
[TBL] [Abstract][Full Text] [Related]
38. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
[TBL] [Abstract][Full Text] [Related]
39. [Different effects of pravastatin on sFlt-1, PlGF and VEGF in different preeclampsia-like mouse models].
Xiang QQ; Yang Z; Huai J; Wang GJ
Zhonghua Fu Chan Ke Za Zhi; 2019 Sep; 54(9):601-607. PubMed ID: 31550776
[No Abstract] [Full Text] [Related]
40. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia.
Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A
J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]